Image may be NSFW.
Clik here to view.
Clik here to view.
Bioasis to file IND for neuro-oncology program
Bioasis Technologies (OTCQX:BIOAF; TSX.V:BTI) has completed efficacy and other tests using Her2+ brain tumor animal models and its lead blood-brain barrier (BBB) delivery vectors, melanotransferrin...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
biOasis to file IND for HER2+ brain cancer treatment in 2016
biOasis (OTCQX:BIOAF; TSX-V:BTI) hopes to file an Investigational New Drug application with the FDA next year to begin human testing of its Transcend platform against HER2 positive brain tumors, which...
View Article
More Pages to Explore .....
